A narrative review on tumor microenvironment in malignant tumors

[1] Weinberg RATboc. The biology of cancer. Garland Science. 2007;725:795. WeinbergRATboc The biology of cancer Garland Science 2007 725 795 Search in Google Scholar

[2] Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discovery. 2022;12(1):31–46. HanahanD Hallmarks of cancer: new dimensions Cancer Discovery 2022 12 1 31 46 Search in Google Scholar

[3] Hanahan D, Weinberg RAJc. The hallmarks of cancer. 2000;100(1):57–70. HanahanD WeinbergRAJc The hallmarks of cancer 2000 100 1 57 70 Search in Google Scholar

[4] Baeriswyl V, Christofori G. The angiogenic switch in carcinogenesis. Seminars in Cancer Biology; 2009: Elsevier. BaeriswylV ChristoforiG The angiogenic switch in carcinogenesis Seminars in Cancer Biology 2009 Elsevier Search in Google Scholar

[5] Hanahan D, Coussens LM. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell. 2012;21(3):309–22. HanahanD CoussensLM Accessories to the crime: functions of cells recruited to the tumor microenvironment Cancer Cell 2012 21 3 309 22 Search in Google Scholar

[6] Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–74. HanahanD WeinbergRA Hallmarks of cancer: the next generation Cell 2011 144 5 646 74 Search in Google Scholar

[7] Junttila MR, de Sauvage FJ. Influence of tumour micro-environment heterogeneity on therapeutic response. Nature. 2013;501(7467):346–54. JunttilaMR de SauvageFJ Influence of tumour micro-environment heterogeneity on therapeutic response Nature 2013 501 7467 346 54 Search in Google Scholar

[8] Chen F, Zhuang X, Lin L, Yu P, Wang Y, Shi Y, Hu G, Sun Y. New horizons in tumor microenvironment biology: challenges and opportunities. BMC Medicine. 2015;13:45. ChenF ZhuangX LinL YuP WangY ShiY HuG SunY New horizons in tumor microenvironment biology: challenges and opportunities BMC Medicine 2015 13 45 Search in Google Scholar

[9] Iwahori K. Cytotoxic CD8(+) Lymphocytes in the tumor microenvironment. Advances in Experimental Medicine and Biology. 2020;1224:53–62. IwahoriK Cytotoxic CD8(+) Lymphocytes in the tumor microenvironment Advances in Experimental Medicine and Biology 2020 1224 53 62 Search in Google Scholar

[10] Li C, Jiang P, Wei S, Xu X, Wang J. Regulatory T cells in tumor microenvironment: new mechanisms, potential therapeutic strategies and future prospects. Molecular Cancer. 2020;19(1):1–23. LiC JiangP WeiS XuX WangJ Regulatory T cells in tumor microenvironment: new mechanisms, potential therapeutic strategies and future prospects Molecular Cancer 2020 19 1 1 23 Search in Google Scholar

[11] Cords, L., de Souza, N., Bodenmiller, B. (2024). Classifying cancer-associated fibroblasts—The good, the bad, and the target. Cancer Cell, 42(9), 1480–1485. CordsL. de SouzaN. BodenmillerB 2024 Classifying cancer-associated fibroblasts—The good, the bad, and the target Cancer Cell 42 9 1480 1485 Search in Google Scholar

[12] Cirri P, Chiarugi P. Cancer associated fibroblasts: the dark side of the coin. American Journal of Cancer Research. 2011;1(4):482–97. CirriP ChiarugiP Cancer associated fibroblasts: the dark side of the coin American Journal of Cancer Research 2011 1 4 482 97 Search in Google Scholar

[13] Öhlund D, Elyada E, Tuveson D. Fibroblast heterogeneity in the cancer wound. The Journal of Experimental Medicine. 2014;211(8):1503–23. Arneth B. Tumor Microenvironment. 2020;56(1):15. ÖhlundD ElyadaE TuvesonD Fibroblast heterogeneity in the cancer wound The Journal of Experimental Medicine 2014 211 8 1503 23 Arneth B. Tumor Microenvironment. 2020;56(1):15. Search in Google Scholar

[14] Li B, Wang JH. Fibroblasts and myofibroblasts in wound healing: force generation and measurement. Journal of Tissue Viability. 2011;20(4):108–20. LiB WangJH Fibroblasts and myofibroblasts in wound healing: force generation and measurement Journal of Tissue Viability 2011 20 4 108 20 Search in Google Scholar

[16] Spaeth EL, Dembinski JL, Sasser AK, Watson K, Klopp A, Hall B, Andreeff M, Marini F. Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression. PloS One. 2009;4(4):e4992. SpaethEL DembinskiJL SasserAK WatsonK KloppA HallB AndreeffM MariniF Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression PloS One 2009 4 4 e4992 Search in Google Scholar

[17] Mbeunkui F, Johann DJ, Jr. Cancer and the tumor microenvironment: a review of an essential relationship. Cancer Chemotherapy and Pharmacology. 2009;63(4):571–82. MbeunkuiF JohannDJJr Cancer and the tumor microenvironment: a review of an essential relationship Cancer Chemotherapy and Pharmacology 2009 63 4 571 82 Search in Google Scholar

[18] Franco OE, Shaw AK, Strand DW, Hayward SW. Cancer associated fibroblasts in cancer pathogenesis. Seminars in Cell & Developmental Biology. 2010;21(1):33–9. FrancoOE ShawAK StrandDW HaywardSW Cancer associated fibroblasts in cancer pathogenesis Seminars in Cell & Developmental Biology 2010 21 1 33 9 Search in Google Scholar

[19] Italiani P, Boraschi D. From Monocytes to M1/M2 Macrophages: Phenotypical vs. Functional Differentiation. 2014;5. ItalianiP BoraschiD From Monocytes to M1/M2 Macrophages: Phenotypical vs. Functional Differentiation 2014 5 Search in Google Scholar

[20] Fan QM, Jing YY, Yu GF, Kou XR, Ye F, Gao L, Li R, Zhao QD, Yang Y, Lu ZH, et al. Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma. Cancer Letters. 2014;352(2):160–8. FanQM JingYY YuGF KouXR YeF GaoL LiR ZhaoQD YangY LuZH Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma Cancer Letters 2014 352 2 160 8 Search in Google Scholar

[21] Fang H, Declerck YA. Targeting the tumor microenvironment: from understanding pathways to effective clinical trials. Cancer Research. 2013;73(16):4965–77. FangH DeclerckYA Targeting the tumor microenvironment: from understanding pathways to effective clinical trials Cancer Research 2013 73 16 4965 77 Search in Google Scholar

[22] Angell H, Galon J. From the immune contexture to the Immunoscore: the role of prognostic and predictive immune markers in cancer. Current Opinion in Immunology. 2013;25(2):261–7. AngellH GalonJ From the immune contexture to the Immunoscore: the role of prognostic and predictive immune markers in cancer Current Opinion in Immunology 2013 25 2 261 7 Search in Google Scholar

[23] Hivroz C, Chemin K, Tourret M, Bohineust A. Crosstalk between T lymphocytes and dendritic cells. Critical Reviews in Immunology. 2012;32(2):139–55. HivrozC CheminK TourretM BohineustA Crosstalk between T lymphocytes and dendritic cells Critical Reviews in Immunology 2012 32 2 139 55 Search in Google Scholar

[24] O’Garra A, Murphy K. Role of cytokines in determining T-lymphocyte function. Current Opinion in Immunology. 1994;6(3):458–66. O’GarraA MurphyK Role of cytokines in determining T-lymphocyte function Current Opinion in Immunology 1994 6 3 458 66 Search in Google Scholar

[25] Fridman WH, Pagès F, Sautès-Fridman C, Galon J. The immune contexture in human tumours: impact on clinical outcome. Nature Reviews Cancer. 2012;12(4):298–306. FridmanWH PagèsF Sautès-FridmanC GalonJ The immune contexture in human tumours: impact on clinical outcome Nature Reviews Cancer 2012 12 4 298 306 Search in Google Scholar

[26] Das A, Sinha M, Datta S, Abas M, Chaffee S, Sen CK, Roy S. Monocyte and macrophage plasticity in tissue repair and regeneration. The American Journal of Pathology. 2015;185(10):2596–606. DasA SinhaM DattaS AbasM ChaffeeS SenCK RoyS Monocyte and macrophage plasticity in tissue repair and regeneration The American Journal of Pathology 2015 185 10 2596 606 Search in Google Scholar

[27] Stout RD, Suttles J. Functional plasticity of macrophages: reversible adaptation to changing microenvironments. Journal of Leukocyte Biology. 2004;76(3):509–13. StoutRD SuttlesJ Functional plasticity of macrophages: reversible adaptation to changing microenvironments Journal of Leukocyte Biology 2004 76 3 509 13 Search in Google Scholar

[28] Li N, Qin J, Lan L, Zhang H, Liu F, Wu Z, Ni H, Wang Y. PTEN inhibits macrophage polarization from M1 to M2 through CCL2 and VEGF-A reduction and NHERF-1 synergism. Cancer Biology & Therapy. 2015;16(2):297–306. LiN QinJ LanL ZhangH LiuF WuZ NiH WangY PTEN inhibits macrophage polarization from M1 to M2 through CCL2 and VEGF-A reduction and NHERF-1 synergism Cancer Biology & Therapy 2015 16 2 297 306 Search in Google Scholar

[29] Derlindati E, Dei Cas A, Montanini B, Spigoni V, Curella V, Aldigeri R, Ardigò D, Zavaroni I, Bonadonna RC. Transcriptomic analysis of human polarized macrophages: more than one role of alternative activation? PloS One. 2015;10(3):e0119751. DerlindatiE Dei CasA MontaniniB SpigoniV CurellaV AldigeriR ArdigòD ZavaroniI BonadonnaRC Transcriptomic analysis of human polarized macrophages: more than one role of alternative activation? PloS One 2015 10 3 e0119751 Search in Google Scholar

[30] Zhao H, Zhang X, Chen X, Li Y, Ke Z, Tang T, Chai H, Guo AM, Chen H, Yang, J. Isoliquiritigenin, a flavonoid from licorice, blocks M2 macrophage polarization in colitis-associated tumorigenesis through downregulating PGE2 and IL-6. Toxicology and Applied Pharmacology. 2014;279(3):311–21. ZhaoH ZhangX ChenX LiY KeZ TangT ChaiH GuoAM ChenH YangJ Isoliquiritigenin, a flavonoid from licorice, blocks M2 macrophage polarization in colitis-associated tumorigenesis through downregulating PGE2 and IL-6 Toxicology and Applied Pharmacology 2014 279 3 311 21 Search in Google Scholar

[31] Josephs DH, Bax HJ, Karagiannis SN. Tumour-associated macrophage polarisation and re-education with immunotherapy. Frontiers in Bioscience (Elite edition). 2015;7(2):293–308. JosephsDH BaxHJ KaragiannisSN Tumour-associated macrophage polarisation and re-education with immunotherapy Frontiers in Bioscience (Elite edition) 2015 7 2 293 308 Search in Google Scholar

[32] Mira E, Carmona-Rodríguez L, Tardáguila M, Azcoitia I, González-Martín A, Almonacid L, Casas J, Fabriás G, Mañes S. A lovastatin-elicited genetic program inhibits M2 macrophage polarization and enhances T cell infiltration into spontaneous mouse mammary tumors. Oncotarget. 2013;4(12):2288–301. MiraE Carmona-RodríguezL TardáguilaM AzcoitiaI González-MartínA AlmonacidL CasasJ FabriásG MañesS A lovastatin-elicited genetic program inhibits M2 macrophage polarization and enhances T cell infiltration into spontaneous mouse mammary tumors Oncotarget 2013 4 12 2288 301 Search in Google Scholar

[33] Hu W, Li X, Zhang C, Yang Y, Jiang J, Wu C. Tumor-associated macrophages in cancers. Clinical & Translational Oncology: Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 2016;18(3):251–8. HuW LiX ZhangC YangY JiangJ WuC Tumor-associated macrophages in cancers Clinical & Translational Oncology: Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2016 18 3 251 8 Search in Google Scholar

[34] Shand FH, Ueha S, Otsuji M, Koid SS, Shichino S, Tsukui T, Kosugi-Kanaya M, Abe J, Tomura M, Ziogas J, et al. Tracking of intertissue migration reveals the origins of tumor-infiltrating monocytes. Proceedings of the National Academy of Sciences of the United States of America. 2014;111(21):7771–6. ShandFH UehaS OtsujiM KoidSS ShichinoS TsukuiT Kosugi-KanayaM AbeJ TomuraM ZiogasJ Tracking of intertissue migration reveals the origins of tumor-infiltrating monocytes Proceedings of the National Academy of Sciences of the United States of America 2014 111 21 7771 6 Search in Google Scholar

[35] Belgiovine C, D’Incalci M, Allavena P, Frapolli R. Tumor-associated macrophages and anti-tumor therapies: complex links. Cellular and molecular life sciences : CMLS. 2016;73(13):2411–24. BelgiovineC D’IncalciM AllavenaP FrapolliR Tumor-associated macrophages and anti-tumor therapies: complex links Cellular and molecular life sciences : CMLS 2016 73 13 2411 24 Search in Google Scholar

[36] Allavena P, Mantovani A. Immunology in the clinic review series; focus on cancer: tumour-associated macrophages: undisputed stars of the inflammatory tumour microenvironment. Clinical and Experimental Immunology. 2012;167(2):195–205. AllavenaP MantovaniA Immunology in the clinic review series; focus on cancer: tumour-associated macrophages: undisputed stars of the inflammatory tumour microenvironment Clinical and Experimental Immunology 2012 167 2 195 205 Search in Google Scholar

[37] Pottier C, Wheatherspoon A, Roncarati P, Longuespée R, Herfs M, Duray A, Delvenne P, Quatresooz P. The importance of the tumor microenvironment in the therapeutic management of cancer. Expert Review of Anticancer Therapy. 2015;15(8):943–54. PottierC WheatherspoonA RoncaratiP LonguespéeR HerfsM DurayA DelvenneP QuatresoozP The importance of the tumor microenvironment in the therapeutic management of cancer Expert Review of Anticancer Therapy 2015 15 8 943 54 Search in Google Scholar

[38] Watnick RS. The role of the tumor microenvironment in regulating angiogenesis. Cold Spring Harbor Perspectives in Medicine. 2012;2(12):a006676. WatnickRS The role of the tumor microenvironment in regulating angiogenesis Cold Spring Harbor Perspectives in Medicine 2012 2 12 a006676 Search in Google Scholar

[39] Nieman KM, Kenny HA, Penicka CV, Ladanyi A, Buell-Gutbrod R, Zillhardt MR, Romero IL, Carey MS, Mills GB, Hotamisligil, GS, et al. Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nature Medicine. 2011;17(11):1498–503. NiemanKM KennyHA PenickaCV LadanyiA Buell-GutbrodR ZillhardtMR RomeroIL CareyMS MillsGB HotamisligilGS Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth Nature Medicine 2011 17 11 1498 503 Search in Google Scholar

[40] Vona-Davis L, Rose DP. Angiogenesis, adipokines and breast cancer. Cytokine & Growth Factor Reviews. 2009;20(3):193–201. Vona-DavisL RoseDP Angiogenesis, adipokines and breast cancer Cytokine & Growth Factor Reviews 2009 20 3 193 201 Search in Google Scholar

[41] Zhang Y, Daquinag AC, Amaya-Manzanares F, Sirin O, Tseng C, Kolonin MG. Stromal progenitor cells from endogenous adipose tissue contribute to pericytes and adipocytes that populate the tumor microenvironment. Cancer Research. 2012;72(20):5198–208. ZhangY DaquinagAC Amaya-ManzanaresF SirinO TsengC KoloninMG Stromal progenitor cells from endogenous adipose tissue contribute to pericytes and adipocytes that populate the tumor microenvironment Cancer Research 2012 72 20 5198 208 Search in Google Scholar

[42] Lee E, Pandey NB, Popel AS. Crosstalk between cancer cells and blood endothelial and lymphatic endothelial cells in tumour and organ microenvironment. Expert Reviews in Molecular Medicine. 2015;17:e3. LeeE PandeyNB PopelAS Crosstalk between cancer cells and blood endothelial and lymphatic endothelial cells in tumour and organ microenvironment Expert Reviews in Molecular Medicine 2015 17 e3 Search in Google Scholar

[43] Cao Y. Opinion: emerging mechanisms of tumour lymphangiogenesis and lymphatic metastasis. Nature Reviews Cancer. 2005;5(9):735–43. CaoY Opinion: emerging mechanisms of tumour lymphangiogenesis and lymphatic metastasis Nature Reviews Cancer 2005 5 9 735 43 Search in Google Scholar

[44] Del Prete A, Schioppa T, Tiberio L, Stabile H, Sozzani S. Leukocyte trafficking in tumor microenvironment. Current Opinion in Pharmacology. 2017;35:40–7. Del PreteA SchioppaT TiberioL StabileH SozzaniS Leukocyte trafficking in tumor microenvironment Current Opinion in Pharmacology 2017 35 40 7 Search in Google Scholar

[45] Ozbek S, Balasubramanian PG, Chiquet-Ehrismann R, Tucker RP, Adams JC. The evolution of extracellular matrix. Molecular Biology of the Cell. 2010;21(24):4300–5. OzbekS BalasubramanianPG Chiquet-EhrismannR TuckerRP AdamsJC The evolution of extracellular matrix Molecular Biology of the Cell 2010 21 24 4300 5 Search in Google Scholar

[46] Xian X, Gopal S, Couchman JR. Syndecans as receptors and organizers of the extracellular matrix. Cell and Tissue Research. 2010;339(1):31–46. XianX GopalS CouchmanJR Syndecans as receptors and organizers of the extracellular matrix Cell and Tissue Research 2010 339 1 31 46 Search in Google Scholar

[47] Weigelt B, Bissell MJ. Unraveling the microenvironmental influences on the normal mammary gland and breast cancer. Seminars in Cancer Biology. 2008;18(5):311–21. WeigeltB BissellMJ Unraveling the microenvironmental influences on the normal mammary gland and breast cancer Seminars in Cancer Biology 2008 18 5 311 21 Search in Google Scholar

[48] Lu P, Weaver VM, Werb Z. The extracellular matrix: a dynamic niche in cancer progression. The Journal of Cell Biology. 2012;196(4):395–406. LuP WeaverVM WerbZ The extracellular matrix: a dynamic niche in cancer progression The Journal of Cell Biology 2012 196 4 395 406 Search in Google Scholar

[49] Morrison VL, Uotila LM, Llort Asens M, Savinko T, Fagerholm SC. Optimal T cell activation and B cell antibody responses in vivo require the interaction between leukocyte function-associated antigen-1 and kindlin-3. Journal of Immunology (Baltimore, Md: 1950). 2015;195(1):105–15. MorrisonVL UotilaLM Llort AsensM SavinkoT FagerholmSC Optimal T cell activation and B cell antibody responses in vivo require the interaction between leukocyte function-associated antigen-1 and kindlin-3 Journal of Immunology (Baltimore, Md: 1950) 2015 195 1 105 15 Search in Google Scholar

[50] Harjunpää H, Llort Asens M, Guenther C, Fagerholm SCJFii. Cell adhesion molecules and their roles and regulation in the immune and tumor microenvironment. 2019;10:1078. HarjunpääH Llort AsensM GuentherC FagerholmSCJFii Cell adhesion molecules and their roles and regulation in the immune and tumor microenvironment 2019 10 1078 Search in Google Scholar

[51] Rai A, Fang H, Claridge B, Simpson RJ, Greening DW. Proteomic dissection of large extracellular vesicle surfaceome unravels interactive surface platform. Journal of Extracellular Vesicles. 2021;10(13):e12164. RaiA FangH ClaridgeB SimpsonRJ GreeningDW Proteomic dissection of large extracellular vesicle surfaceome unravels interactive surface platform Journal of Extracellular Vesicles 2021 10 13 e12164 Search in Google Scholar

[52] Walker C, Mojares E, Del Río Hernández A. Role of extracellular matrix in development and cancer progression. International Journal of Molecular Sciences. 2018;19(10). WalkerC MojaresE Del Río HernándezA Role of extracellular matrix in development and cancer progression International Journal of Molecular Sciences 2018 19 10 Search in Google Scholar

[53] McAndrews KM, McGrail DJ, Ravikumar N, Dawson MR. Mesenchymal stem cells induce directional migration of invasive breast cancer cells through TGF-β. Scientific Reports. 2015;5(1):16941. McAndrewsKM McGrailDJ RavikumarN DawsonMR Mesenchymal stem cells induce directional migration of invasive breast cancer cells through TGF-β Scientific Reports 2015 5 1 16941 Search in Google Scholar

[54] Hynes RO. The extracellular matrix: Not just pretty fibrils. Science (New York, NY). 2009;326(5957):1216–9. HynesRO The extracellular matrix: Not just pretty fibrils Science (New York, NY) 2009 326 5957 1216 9 Search in Google Scholar

[55] Yi, M., Li, T., Niu, M. (2024). Targeting cytokine and chemokine signaling pathways for cancer therapy. Signal Transduction and Targeted Therapy. 9, 176. YiM. LiT. NiuM. 2024 Targeting cytokine and chemokine signaling pathways for cancer therapy Signal Transduction and Targeted Therapy 9 176 Search in Google Scholar

[56] Tartour E, Fridman WH. Cytokines and cancer. International Reviews of Immunology. 1998;16(5–6):683–704. TartourE FridmanWH Cytokines and cancer International Reviews of Immunology 1998 16 5–6 683 704 Search in Google Scholar

[57] Balkwill F. Cancer and the chemokine network. Nature Reviews Cancer. 2004;4(7):540–50. BalkwillF Cancer and the chemokine network Nature Reviews Cancer 2004 4 7 540 50 Search in Google Scholar

[58] Chow MT, Luster AD. Chemokines in cancer. Cancer Immunology Research. 2014;2(12):1125–31. ChowMT LusterAD Chemokines in cancer Cancer Immunology Research 2014 2 12 1125 31 Search in Google Scholar

[59] Upadhyay A. Cancer: An unknown territory; rethinking before going ahead. Genes & Diseases. 2021;8(5):655–61. UpadhyayA Cancer: An unknown territory; rethinking before going ahead Genes & Diseases 2021 8 5 655 61 Search in Google Scholar

[60] Vaupel P, Mayer A. Hypoxia in tumors: pathogenesis-related classification, characterization of hypoxia subtypes, and associated biological and clinical implications. Advances in Experimental Medicine and Biology. 2014;812:19–24. VaupelP MayerA Hypoxia in tumors: pathogenesis-related classification, characterization of hypoxia subtypes, and associated biological and clinical implications Advances in Experimental Medicine and Biology 2014 812 19 24 Search in Google Scholar

[61] Hulikova A, Swietach P. Rapid CO₂ permeation across biological membranes: implications for CO₂ venting from tissue. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology. 2014;28(7):2762–74. HulikovaA SwietachP Rapid CO₂ permeation across biological membranes: implications for CO₂ venting from tissue FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology 2014 28 7 2762 74 Search in Google Scholar

[62] Chiche J, Brahimi-Horn MC, Pouysségur J. Tumour hypoxia induces a metabolic shift causing acidosis: a common feature in cancer. Journal of cellular and molecular medicine. 2010;14(4):771–94. ChicheJ Brahimi-HornMC PouysségurJ Tumour hypoxia induces a metabolic shift causing acidosis: a common feature in cancer Journal of cellular and molecular medicine 2010 14 4 771 94 Search in Google Scholar

[63] Semenza GL. Targeting HIF-1 for cancer therapy. Nature Reviews Cancer. 2003;3(10):721–32. SemenzaGL Targeting HIF-1 for cancer therapy Nature Reviews Cancer 2003 3 10 721 32 Search in Google Scholar

[64] Kunz M, Ibrahim SM. Molecular responses to hypoxia in tumor cells. Molecular Cancer. 2003;2:23. KunzM IbrahimSM Molecular responses to hypoxia in tumor cells Molecular Cancer 2003 2 23 Search in Google Scholar

[65] Elinav E, Garrett WS, Trinchieri G, Wargo J. The cancer microbiome. Nature Reviews Cancer. 2019;19(7):371–6. ElinavE GarrettWS TrinchieriG WargoJ The cancer microbiome Nature Reviews Cancer 2019 19 7 371 6 Search in Google Scholar

[66] Ungefroren H, Sebens S, Seidl D, Lehnert H, Hass R. Interaction of tumor cells with the microenvironment. Cell Communication Signaling. 2011;9(1):1–8. UngefrorenH SebensS SeidlD LehnertH HassR Interaction of tumor cells with the microenvironment Cell Communication Signaling 2011 9 1 1 8 Search in Google Scholar

[67] Brábek J, Mierke CT, Rösel D, Veselý P, Fabry B. The role of the tissue microenvironment in the regulation of cancer cell motility and invasion. Cell Communication and Signaling: CCS. 2010;8:22. BrábekJ MierkeCT RöselD VeselýP FabryB The role of the tissue microenvironment in the regulation of cancer cell motility and invasion Cell Communication and Signaling: CCS 2010 8 22 Search in Google Scholar

[68] Friedl P, Wolf K. Plasticity of cell migration: a multiscale tuning model. The Journal of Cell Biology. 2010;188(1):11–9. FriedlP WolfK Plasticity of cell migration: a multiscale tuning model The Journal of Cell Biology 2010 188 1 11 9 Search in Google Scholar

[69] Levental KR, Yu H, Kass L, Lakins JN, Egeblad M, Erler JT, Fong SFT, Csiszar K, Giaccia A, Weninger W, et al. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell. 2009;139(5):891–906. LeventalKR YuH KassL LakinsJN EgebladM ErlerJT FongSFT CsiszarK GiacciaA WeningerW Matrix crosslinking forces tumor progression by enhancing integrin signaling Cell 2009 139 5 891 906 Search in Google Scholar

[70] He X, Lee B, Jiang Y. Cell-ECM interactions in tumor invasion. Advances in Experimental Medicine and Biology. 2016;936:73–91. HeX LeeB JiangY Cell-ECM interactions in tumor invasion Advances in Experimental Medicine and Biology 2016 936 73 91 Search in Google Scholar

[71] Boedtkjer E, Pedersen SF. The acidic tumor microenvironment as a driver of cancer. Annual Review of Physiology. 2020;82:103–26. BoedtkjerE PedersenSF The acidic tumor microenvironment as a driver of cancer Annual Review of Physiology 2020 82 103 26 Search in Google Scholar

[72] Huber V, Camisaschi C, Berzi A, Ferro S, Lugini L, Triulzi T, Tuccitto A, Tagliabue E, Castelli C, Rivoltini L. Cancer acidity: An ultimate frontier of tumor immune escape and a novel target of immunomodulation. Seminars in Cancer Biology. 2017;43:74–89. HuberV CamisaschiC BerziA FerroS LuginiL TriulziT TuccittoA TagliabueE CastelliC RivoltiniL Cancer acidity: An ultimate frontier of tumor immune escape and a novel target of immunomodulation Seminars in Cancer Biology 2017 43 74 89 Search in Google Scholar

[73] Zhou ZH, Song JW, Li W, Liu X, Cao L, Wan LM, Tan YX, Ji SP, Liang YM, Gong F. The acid-sensing ion channel, ASIC2, promotes invasion and metastasis of colorectal cancer under acidosis by activating the calcineurin/NFAT1 axis. Journal of Experimental & Clinical Cancer Research: CR. 2017;36(1):130. ZhouZH SongJW LiW LiuX CaoL WanLM TanYX JiSP LiangYM GongF The acid-sensing ion channel, ASIC2, promotes invasion and metastasis of colorectal cancer under acidosis by activating the calcineurin/NFAT1 axis Journal of Experimental & Clinical Cancer Research: CR 2017 36 1 130 Search in Google Scholar

[74] Lyssiotis CA, Kimmelman AC. Metabolic interactions in the tumor microenvironment. Trends in Cell Biology. 2017;27(11):863–75. LyssiotisCA KimmelmanAC Metabolic interactions in the tumor microenvironment Trends in Cell Biology 2017 27 11 863 75 Search in Google Scholar

[75] Yu J, Zhang Q, Wang M, Liang S, Huang H, Xie L, Cui C, Yu J. Comprehensive analysis of tumor mutation burden and immune microenvironment in gastric cancer. Bioscience Reports. 2021; 41(2). YuJ ZhangQ WangM LiangS HuangH XieL CuiC YuJ Comprehensive analysis of tumor mutation burden and immune microenvironment in gastric cancer Bioscience Reports 2021 41 2 Search in Google Scholar

[76] Zhu Y, Zhao Y, Cao Z, Chen Z, Pan W. Identification of three immune subtypes characterized by distinct tumor immune microenvironment and therapeutic response in stomach adenocarcinoma. Gene. 2022;818:146177. ZhuY ZhaoY CaoZ ChenZ PanW Identification of three immune subtypes characterized by distinct tumor immune microenvironment and therapeutic response in stomach adenocarcinoma Gene 2022 818 146177 Search in Google Scholar

[77] Wang Y, Zhu GQ, Tian D, Zhou CW, Li N, Feng Y, Zeng MS. Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer. BMC Cancer. 2022;22(1):316. WangY ZhuGQ TianD ZhouCW LiN FengY ZengMS Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer BMC Cancer 2022 22 1 316 Search in Google Scholar

[78] Kim EY, Abdul-Ghafar J, Chong Y, Yim K. Calculated tumor-associated neutrophils are associated with the tumor-stroma ratio and predict a poor prognosis in advanced gastric cancer. Biomedicines. 2022;10(3). KimEY Abdul-GhafarJ ChongY YimK Calculated tumor-associated neutrophils are associated with the tumor-stroma ratio and predict a poor prognosis in advanced gastric cancer Biomedicines 2022 10 3 Search in Google Scholar

[79] Mao X, Xu J, Wang W, Liang C, Hua J, Liu J, Zhang B, Meng Q, Yu X, Shi S. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives. Molecular Cancer. 2021;20(1):131. MaoX XuJ WangW LiangC HuaJ LiuJ ZhangB MengQ YuX ShiS Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives Molecular Cancer 2021 20 1 131 Search in Google Scholar

[80] Hao NB, Lü MH, Fan YH, Cao YL, Zhang ZR, Yang SM. Macrophages in tumor microenvironments and the progression of tumors. Clinical & Developmental Immunology. 2012;2012:948098. HaoNB LüMH FanYH CaoYL ZhangZR YangSM Macrophages in tumor microenvironments and the progression of tumors Clinical & Developmental Immunology 2012 2012 948098 Search in Google Scholar

[81] Okikawa S, Morine Y, Saito Y, Yamada S, Tokuda K, Teraoku H, Miyazaki K, Yamashita S, Ikemoto T, Imura S, et al. Inhibition of the VEGF signaling pathway attenuates tumor-associated macrophage activity in liver cancer. Oncology Reports. 2022;47(4). OkikawaS MorineY SaitoY YamadaS TokudaK TeraokuH MiyazakiK YamashitaS IkemotoT ImuraS Inhibition of the VEGF signaling pathway attenuates tumor-associated macrophage activity in liver cancer Oncology Reports 2022 47 4 Search in Google Scholar

[82] Ao T, Mochizuki S, Kajiwara Y, Yonemura K, Shiraishi T, Nagata K, Shinto E, Okamoto K, Nearchou IP, Shimazaki H, et al. Cancer-associated fibroblasts at the unfavorable desmoplastic stroma promote colorectal cancer aggressiveness: Potential role of ADAM9. International Journal of Cancer. 2022;150(10):1706–21. AoT MochizukiS KajiwaraY YonemuraK ShiraishiT NagataK ShintoE OkamotoK NearchouIP ShimazakiH Cancer-associated fibroblasts at the unfavorable desmoplastic stroma promote colorectal cancer aggressiveness: Potential role of ADAM9 International Journal of Cancer 2022 150 10 1706 21 Search in Google Scholar

[83] Ugai T, Väyrynen JP, Lau MC, Borowsky J, Akimoto N, Väyrynen SA, Zhao M, Zhong R, Haruki K, Costa AD, et al. Immune cell profiles in the tumor microenvironment of early-onset, intermediate-onset, and later-onset colorectal cancer. Cancer Immunology, Immunotherapy: CII. 2022;71(4):933–42. UgaiT VäyrynenJP LauMC BorowskyJ AkimotoN VäyrynenSA ZhaoM ZhongR HarukiK CostaAD Immune cell profiles in the tumor microenvironment of early-onset, intermediate-onset, and later-onset colorectal cancer Cancer Immunology, Immunotherapy: CII 2022 71 4 933 42 Search in Google Scholar

[84] Ren C, Li J, Zhou Y, Zhang S, Wang Q. Typical tumor immune microenvironment status determine prognosis in lung adenocarcinoma. Translational Oncology. 2022;18:101367. RenC LiJ ZhouY ZhangS WangQ Typical tumor immune microenvironment status determine prognosis in lung adenocarcinoma Translational Oncology 2022 18 101367 Search in Google Scholar

[85] Sumitomo R, Huang CL, Fujita M, Cho H, Date H. Differential expression of PD-L1 and PD-L2 is associated with the tumor microenvironment of TILs and M2 TAMs and tumor differentiation in non-small cell lung cancer. Oncology Reports. 2022;47(4). SumitomoR HuangCL FujitaM ChoH DateH Differential expression of PD-L1 and PD-L2 is associated with the tumor microenvironment of TILs and M2 TAMs and tumor differentiation in non-small cell lung cancer Oncology Reports 2022 47 4 Search in Google Scholar

[86] Liu Y, Wang T, Fang Z, Kong J, Liu J. Analysis of N6-methyladenosine-related lncRNAs in the tumor immune microenvironment and their prognostic role in pancreatic cancer. J Cancer Res Clin Oncol. 2022;148(7):1613–1626. LiuY WangT FangZ KongJ LiuJ Analysis of N6-methyladenosine-related lncRNAs in the tumor immune microenvironment and their prognostic role in pancreatic cancer J Cancer Res Clin Oncol 2022 148 7 1613 1626 Search in Google Scholar

[87] Li TJ, Jin KZ, Li H, Ye LY, Li PC, Jiang B, Lin X, Liao ZY, Zhang HR, Shi SM, et al. SIGLEC15 amplifies immunosuppressive properties of tumor-associated macrophages in pancreatic cancer. Cancer Letters. 2022;530:142–55. LiTJ JinKZ LiH YeLY LiPC JiangB LinX LiaoZY ZhangHR ShiSM SIGLEC15 amplifies immunosuppressive properties of tumor-associated macrophages in pancreatic cancer Cancer Letters 2022 530 142 55 Search in Google Scholar

[88] Hornburg M, Desbois M, Lu S, Guan Y, Lo AA, Kaufman S, Elrod A, Lotstein A, DesRochers TM, Munoz-Rodriguez JL, et al. Single-cell dissection of cellular components and interactions shaping the tumor immune phenotypes in ovarian cancer. Cancer Cell. 2021;39(7):928–44.e6. HornburgM DesboisM LuS GuanY LoAA KaufmanS ElrodA LotsteinA DesRochersTM Munoz-RodriguezJL Single-cell dissection of cellular components and interactions shaping the tumor immune phenotypes in ovarian cancer Cancer Cell 2021 39 7 928 44.e6 Search in Google Scholar

[89] Najem H, Ott M, Kassab C, Rao A, Rao G, Marisetty A, Sonabend AM, Horbinski C, Verhaak R, Shankar A, et al. Central nervous system immune interactome is a function of cancer lineage, tumor microenvironment, and STAT3 expression. JCI Insight. 2022 Sep;7(9):e157612. NajemH OttM KassabC RaoA RaoG MarisettyA SonabendAM HorbinskiC VerhaakR ShankarA Central nervous system immune interactome is a function of cancer lineage, tumor microenvironment, and STAT3 expression JCI Insight 2022 Sep 7 9 e157612 Search in Google Scholar

[90] Wang QW, Bao ZS, Jiang T, Zhu YJ. Tumor microenvironment is associated with clinical and genetic properties of diffuse gliomas and predicts overall survival. Cancer Immunology, Immunotherapy: CII. 2022;71(4):953–66. WangQW BaoZS JiangT ZhuYJ Tumor microenvironment is associated with clinical and genetic properties of diffuse gliomas and predicts overall survival Cancer Immunology, Immunotherapy: CII 2022 71 4 953 66 Search in Google Scholar

[91] Teng YHF, Quah HS, Suteja L, Dias JML, Mupo A, Bashford-Rogers RJM, Vassiliou GS, Chua MLK, Tan DSW, Tan DSW, et al. Analysis of T cell receptor clonotypes in tumor microenvironment identifies shared cancer-type-specific signatures. Cancer Immunology, Immunotherapy: CII. 2022;71(4):989–98. TengYHF QuahHS SutejaL DiasJML MupoA Bashford-RogersRJM VassiliouGS ChuaMLK TanDSW TanDSW Analysis of T cell receptor clonotypes in tumor microenvironment identifies shared cancer-type-specific signatures Cancer Immunology, Immunotherapy: CII 2022 71 4 989 98 Search in Google Scholar

[92] Ma L, Hernandez MO, Zhao Y, Mehta M, Tran B, Kelly M, Rae Z, Hernandez JM, Davis JL, Martin SP, et al. Tumor cell biodiversity drives microenvironmental reprogramming in liver cancer. 2019;36(4):418–30. e6. MaL HernandezMO ZhaoY MehtaM TranB KellyM RaeZ HernandezJM DavisJL MartinSP Tumor cell biodiversity drives microenvironmental reprogramming in liver cancer 2019 36 4 418 30. e6 Search in Google Scholar

[93] Ravi VM, Neidert N, Will P, Joseph K, Maier JP, Kückelhaus J, Vollmer L, Goeldner JM, Behringer SP, Scherer F, et al. T-cell dysfunction in the glioblastoma microenvironment is mediated by myeloid cells releasing interleukin-10. Nature Communications. 2022;13(1):925. RaviVM NeidertN WillP JosephK MaierJP KückelhausJ VollmerL GoeldnerJM BehringerSP SchererF T-cell dysfunction in the glioblastoma microenvironment is mediated by myeloid cells releasing interleukin-10 Nature Communications 2022 13 1 925 Search in Google Scholar

[94] Du Y, Shi J, Wang J, Xun Z, Yu Z, Sun H, Bao R, Zheng J, Li Z, Ye Y. Integration of pan-cancer single-cell and spatial transcriptomics reveals stromal cell features and therapeutic targets in tumor microenvironment. Cancer Research. 2024;84(2):192–210. DuY ShiJ WangJ XunZ YuZ SunH BaoR ZhengJ LiZ YeY Integration of pan-cancer single-cell and spatial transcriptomics reveals stromal cell features and therapeutic targets in tumor microenvironment Cancer Research 2024 84 2 192 210 Search in Google Scholar

[95] Zha C, Meng X, Li L, Mi S, Qian D, Li Z, Wu P, Hu S, Zhao S, Cai J, et al. Neutrophil extracellular traps mediate the crosstalk between glioma progression and the tumor microenvironment via the HMGB1/RAGE/IL-8 axis. Cancer Biology & Medicine. 2020;17(1):154–68. ZhaC MengX LiL MiS QianD LiZ WuP HuS ZhaoS CaiJ Neutrophil extracellular traps mediate the crosstalk between glioma progression and the tumor microenvironment via the HMGB1/RAGE/IL-8 axis Cancer Biology & Medicine 2020 17 1 154 68 Search in Google Scholar

[96] Seo MK, Kang H, Kim S. Tumor microenvironment-aware, single-transcriptome prediction of microsatellite instability in colorectal cancer using meta-analysis. Scientific Reports. 2022;12(1):6283. SeoMK KangH KimS Tumor microenvironment-aware, single-transcriptome prediction of microsatellite instability in colorectal cancer using meta-analysis Scientific Reports 2022 12 1 6283 Search in Google Scholar

[97] He C, Wang D, Shukla SK, Hu T, Thakur R, Fu X, King RJ, Kollala SS, Attri KS, Murthy D, et al. Vitamin B6 competition in the tumor microenvironment hampers antitumor functions of NK cells. Cancer Discovery. 2024;14(1):176–93. HeC WangD ShuklaSK HuT ThakurR FuX KingRJ KollalaSS AttriKS MurthyD Vitamin B6 competition in the tumor microenvironment hampers antitumor functions of NK cells Cancer Discovery 2024 14 1 176 93 Search in Google Scholar

[98] Chen X, Yuan Q, Liu J, Xia S, Shi X, Su Y, Wang Z, Li S, Shang D. Comprehensive characterization of extracellular matrix-related genes in PAAD identified a novel prognostic panel related to clinical outcomes and immune microenvironment: A silico analysis with in vivo and vitro validation. Frontiers in Immunology. 2022;13:985911. ChenX YuanQ LiuJ XiaS ShiX SuY WangZ LiS ShangD Comprehensive characterization of extracellular matrix-related genes in PAAD identified a novel prognostic panel related to clinical outcomes and immune microenvironment: A silico analysis with in vivo and vitro validation Frontiers in Immunology 2022 13 985911 Search in Google Scholar

[99] Xiao Y, Yu D. Tumor microenvironment as a therapeutic target in cancer. Pharmacology & Therapeutics. 2021;221:107753. XiaoY YuD Tumor microenvironment as a therapeutic target in cancer Pharmacology & Therapeutics 2021 221 107753 Search in Google Scholar

[100] Rahmanian M, Seyfoori A, Ghasemi M, Shamsi M, Kolahchi AR, Modarres HP, Sanati-Nezhad A, Majidzadeh-A K. In-vitro tumor microenvironment models containing physical and biological barriers for modelling multidrug resistance mechanisms and multidrug delivery strategies. Journal of Controlled Release. 2021;334:164–77. RahmanianM SeyfooriA GhasemiM ShamsiM KolahchiAR ModarresHP Sanati-NezhadA Majidzadeh-AK In-vitro tumor microenvironment models containing physical and biological barriers for modelling multidrug resistance mechanisms and multidrug delivery strategies Journal of Controlled Release 2021 334 164 77 Search in Google Scholar